Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSPN | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | MPV17L2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | CTSH | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | ANXA3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | MAL2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | CDKN1A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | PGBD1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | KIFC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | PNMA1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |